nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC15A2—choroid plexus—malignant glioma	0.181	0.438	CbGeAlD
Cefdinir—MPO—endothelium—malignant glioma	0.0409	0.099	CbGeAlD
Cefdinir—MPO—blood vessel—malignant glioma	0.0377	0.0913	CbGeAlD
Cefdinir—Interstitial pneumonia—Temozolomide—malignant glioma	0.0262	0.0481	CcSEcCtD
Cefdinir—Nephropathy toxic—Carmustine—malignant glioma	0.0228	0.0418	CcSEcCtD
Cefdinir—Digestion impaired—Temozolomide—malignant glioma	0.0189	0.0347	CcSEcCtD
Cefdinir—Interstitial lung disease—Carmustine—malignant glioma	0.0185	0.034	CcSEcCtD
Cefdinir—Interstitial lung disease—Temozolomide—malignant glioma	0.0179	0.0328	CcSEcCtD
Cefdinir—Cholestasis—Temozolomide—malignant glioma	0.0167	0.0306	CcSEcCtD
Cefdinir—Coagulopathy—Temozolomide—malignant glioma	0.0162	0.0298	CcSEcCtD
Cefdinir—SLC15A2—retina—malignant glioma	0.0138	0.0335	CbGeAlD
Cefdinir—MPO—spinal cord—malignant glioma	0.0128	0.031	CbGeAlD
Cefdinir—SLC15A2—telencephalon—malignant glioma	0.0127	0.0308	CbGeAlD
Cefdinir—Vaginal inflammation—Temozolomide—malignant glioma	0.0126	0.0232	CcSEcCtD
Cefdinir—Candida infection—Carmustine—malignant glioma	0.0125	0.0229	CcSEcCtD
Cefdinir—Candida infection—Temozolomide—malignant glioma	0.0121	0.0222	CcSEcCtD
Cefdinir—SLC22A5—retina—malignant glioma	0.012	0.0291	CbGeAlD
Cefdinir—Vaginal infection—Temozolomide—malignant glioma	0.0119	0.0219	CcSEcCtD
Cefdinir—Aplastic anaemia—Temozolomide—malignant glioma	0.0119	0.0218	CcSEcCtD
Cefdinir—MPO—central nervous system—malignant glioma	0.0104	0.0252	CbGeAlD
Cefdinir—Hepatic failure—Temozolomide—malignant glioma	0.0102	0.0188	CcSEcCtD
Cefdinir—SLC15A2—medulla oblongata—malignant glioma	0.00998	0.0242	CbGeAlD
Cefdinir—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00973	0.0179	CcSEcCtD
Cefdinir—Purpura—Temozolomide—malignant glioma	0.00953	0.0175	CcSEcCtD
Cefdinir—SLC15A2—midbrain—malignant glioma	0.00912	0.0221	CbGeAlD
Cefdinir—SLC15A2—spinal cord—malignant glioma	0.0089	0.0216	CbGeAlD
Cefdinir—SLC22A5—medulla oblongata—malignant glioma	0.00868	0.021	CbGeAlD
Cefdinir—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00827	0.0152	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00827	0.0152	CcSEcCtD
Cefdinir—MPO—brain—malignant glioma	0.00825	0.02	CbGeAlD
Cefdinir—SLC22A5—midbrain—malignant glioma	0.00794	0.0192	CbGeAlD
Cefdinir—Pancytopenia—Carmustine—malignant glioma	0.0078	0.0143	CcSEcCtD
Cefdinir—SLC22A5—spinal cord—malignant glioma	0.00774	0.0188	CbGeAlD
Cefdinir—Neutropenia—Carmustine—malignant glioma	0.00768	0.0141	CcSEcCtD
Cefdinir—Pancytopenia—Temozolomide—malignant glioma	0.00754	0.0138	CcSEcCtD
Cefdinir—Neutropenia—Temozolomide—malignant glioma	0.00742	0.0136	CcSEcCtD
Cefdinir—Pneumonia—Carmustine—malignant glioma	0.00736	0.0135	CcSEcCtD
Cefdinir—SLC15A2—central nervous system—malignant glioma	0.00722	0.0175	CbGeAlD
Cefdinir—Renal failure—Carmustine—malignant glioma	0.0072	0.0132	CcSEcCtD
Cefdinir—Stomatitis—Carmustine—malignant glioma	0.00714	0.0131	CcSEcCtD
Cefdinir—Pneumonia—Temozolomide—malignant glioma	0.00712	0.0131	CcSEcCtD
Cefdinir—SLC15A2—cerebellum—malignant glioma	0.00706	0.0171	CbGeAlD
Cefdinir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00702	0.0129	CcSEcCtD
Cefdinir—Stomatitis—Temozolomide—malignant glioma	0.0069	0.0127	CcSEcCtD
Cefdinir—Haemoglobin—Carmustine—malignant glioma	0.00661	0.0121	CcSEcCtD
Cefdinir—Haemorrhage—Carmustine—malignant glioma	0.00657	0.0121	CcSEcCtD
Cefdinir—Haemoglobin—Temozolomide—malignant glioma	0.00638	0.0117	CcSEcCtD
Cefdinir—Haemorrhage—Temozolomide—malignant glioma	0.00635	0.0117	CcSEcCtD
Cefdinir—SLC22A5—cerebellum—malignant glioma	0.00614	0.0149	CbGeAlD
Cefdinir—Erythema multiforme—Temozolomide—malignant glioma	0.00601	0.011	CcSEcCtD
Cefdinir—SLC15A2—brain—malignant glioma	0.00573	0.0139	CbGeAlD
Cefdinir—Agitation—Carmustine—malignant glioma	0.00526	0.00965	CcSEcCtD
Cefdinir—Leukopenia—Carmustine—malignant glioma	0.00512	0.0094	CcSEcCtD
Cefdinir—Agitation—Temozolomide—malignant glioma	0.00508	0.00933	CcSEcCtD
Cefdinir—SLC22A5—brain—malignant glioma	0.00499	0.0121	CbGeAlD
Cefdinir—Convulsion—Carmustine—malignant glioma	0.00496	0.0091	CcSEcCtD
Cefdinir—Leukopenia—Temozolomide—malignant glioma	0.00495	0.00909	CcSEcCtD
Cefdinir—Hypertension—Carmustine—malignant glioma	0.00494	0.00907	CcSEcCtD
Cefdinir—Chest pain—Carmustine—malignant glioma	0.00487	0.00894	CcSEcCtD
Cefdinir—Convulsion—Temozolomide—malignant glioma	0.00479	0.0088	CcSEcCtD
Cefdinir—Hypertension—Temozolomide—malignant glioma	0.00477	0.00876	CcSEcCtD
Cefdinir—Dry mouth—Temozolomide—malignant glioma	0.0046	0.00845	CcSEcCtD
Cefdinir—Thrombocytopenia—Carmustine—malignant glioma	0.00457	0.00839	CcSEcCtD
Cefdinir—Anaphylactic shock—Temozolomide—malignant glioma	0.00451	0.00829	CcSEcCtD
Cefdinir—Anorexia—Carmustine—malignant glioma	0.00445	0.00817	CcSEcCtD
Cefdinir—Thrombocytopenia—Temozolomide—malignant glioma	0.00442	0.00811	CcSEcCtD
Cefdinir—Anorexia—Temozolomide—malignant glioma	0.0043	0.0079	CcSEcCtD
Cefdinir—Insomnia—Carmustine—malignant glioma	0.00422	0.00775	CcSEcCtD
Cefdinir—Somnolence—Carmustine—malignant glioma	0.00415	0.00762	CcSEcCtD
Cefdinir—Insomnia—Temozolomide—malignant glioma	0.00408	0.00749	CcSEcCtD
Cefdinir—Decreased appetite—Carmustine—malignant glioma	0.00406	0.00745	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00403	0.0074	CcSEcCtD
Cefdinir—Somnolence—Temozolomide—malignant glioma	0.00401	0.00737	CcSEcCtD
Cefdinir—Constipation—Carmustine—malignant glioma	0.00399	0.00733	CcSEcCtD
Cefdinir—Dyspepsia—Temozolomide—malignant glioma	0.00397	0.00729	CcSEcCtD
Cefdinir—Decreased appetite—Temozolomide—malignant glioma	0.00392	0.0072	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0039	0.00715	CcSEcCtD
Cefdinir—Constipation—Temozolomide—malignant glioma	0.00386	0.00709	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—YEATS4—malignant glioma	0.00384	0.0903	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Carmustine—malignant glioma	0.00382	0.00701	CcSEcCtD
Cefdinir—Abdominal pain—Carmustine—malignant glioma	0.00369	0.00678	CcSEcCtD
Cefdinir—Body temperature increased—Carmustine—malignant glioma	0.00369	0.00678	CcSEcCtD
Cefdinir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00369	0.00678	CcSEcCtD
Cefdinir—Body temperature increased—Temozolomide—malignant glioma	0.00357	0.00655	CcSEcCtD
Cefdinir—Abdominal pain—Temozolomide—malignant glioma	0.00357	0.00655	CcSEcCtD
Cefdinir—Hypersensitivity—Carmustine—malignant glioma	0.00344	0.00632	CcSEcCtD
Cefdinir—Asthenia—Carmustine—malignant glioma	0.00335	0.00615	CcSEcCtD
Cefdinir—Hypersensitivity—Temozolomide—malignant glioma	0.00332	0.0061	CcSEcCtD
Cefdinir—Asthenia—Temozolomide—malignant glioma	0.00324	0.00594	CcSEcCtD
Cefdinir—Diarrhoea—Carmustine—malignant glioma	0.0032	0.00587	CcSEcCtD
Cefdinir—Pruritus—Temozolomide—malignant glioma	0.00319	0.00586	CcSEcCtD
Cefdinir—Dizziness—Carmustine—malignant glioma	0.00309	0.00567	CcSEcCtD
Cefdinir—Diarrhoea—Temozolomide—malignant glioma	0.00309	0.00567	CcSEcCtD
Cefdinir—Dizziness—Temozolomide—malignant glioma	0.00298	0.00548	CcSEcCtD
Cefdinir—Vomiting—Carmustine—malignant glioma	0.00297	0.00545	CcSEcCtD
Cefdinir—Rash—Carmustine—malignant glioma	0.00294	0.00541	CcSEcCtD
Cefdinir—Dermatitis—Carmustine—malignant glioma	0.00294	0.0054	CcSEcCtD
Cefdinir—Headache—Carmustine—malignant glioma	0.00293	0.00537	CcSEcCtD
Cefdinir—Vomiting—Temozolomide—malignant glioma	0.00287	0.00527	CcSEcCtD
Cefdinir—Rash—Temozolomide—malignant glioma	0.00285	0.00522	CcSEcCtD
Cefdinir—Dermatitis—Temozolomide—malignant glioma	0.00284	0.00522	CcSEcCtD
Cefdinir—Headache—Temozolomide—malignant glioma	0.00283	0.00519	CcSEcCtD
Cefdinir—Nausea—Carmustine—malignant glioma	0.00277	0.00509	CcSEcCtD
Cefdinir—Nausea—Temozolomide—malignant glioma	0.00268	0.00492	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—PIM1—malignant glioma	0.00197	0.0462	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL12B—malignant glioma	0.00185	0.0435	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CSF1—malignant glioma	0.00174	0.041	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYB—malignant glioma	0.00131	0.0309	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD1—malignant glioma	0.00117	0.0274	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00107	0.0252	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000996	0.0234	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.000995	0.0234	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SOD1—malignant glioma	0.00095	0.0223	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CAT—malignant glioma	0.000902	0.0212	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—F2—malignant glioma	0.000813	0.0191	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—malignant glioma	0.000796	0.0187	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SOD1—malignant glioma	0.000755	0.0177	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CAT—malignant glioma	0.000717	0.0168	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—malignant glioma	0.00071	0.0167	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL2—malignant glioma	0.000707	0.0166	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—HES1—malignant glioma	0.000707	0.0166	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—NCOR1—malignant glioma	0.000703	0.0165	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—F2—malignant glioma	0.000661	0.0155	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.000631	0.0148	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—malignant glioma	0.000616	0.0145	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0006	0.0141	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—malignant glioma	0.000595	0.014	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.000586	0.0138	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000557	0.0131	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—malignant glioma	0.000549	0.0129	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000548	0.0129	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000539	0.0127	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—F2—malignant glioma	0.000525	0.0123	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—malignant glioma	0.000515	0.0121	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IFNG—malignant glioma	0.000501	0.0118	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3CA—malignant glioma	0.00047	0.011	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL1B—malignant glioma	0.000447	0.0105	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL2—malignant glioma	0.000445	0.0105	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN2A—malignant glioma	0.000424	0.00996	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—malignant glioma	0.000417	0.0098	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—malignant glioma	0.000399	0.00937	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—malignant glioma	0.000398	0.00936	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—malignant glioma	0.000396	0.00931	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000392	0.00922	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000382	0.00897	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000364	0.00855	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000359	0.00843	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000358	0.00841	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—malignant glioma	0.000355	0.00834	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000333	0.00782	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000327	0.00769	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—malignant glioma	0.000324	0.00762	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000314	0.00737	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000305	0.00717	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000291	0.00684	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYC—malignant glioma	0.000287	0.00675	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000286	0.00673	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—malignant glioma	0.000286	0.00672	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000283	0.00665	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000282	0.00663	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOD—malignant glioma	0.000278	0.00654	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000269	0.00631	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KRAS—malignant glioma	0.000265	0.00623	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000262	0.00615	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—malignant glioma	0.000258	0.00606	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000258	0.00605	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000249	0.00586	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000245	0.00576	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000156	0.00367	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000145	0.00341	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000143	0.00337	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000143	0.00335	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000136	0.00321	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000133	0.00313	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000131	0.00308	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000127	0.00298	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000125	0.00293	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—RAF1—malignant glioma	6.18e-05	0.00145	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.74e-05	0.00135	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	5.65e-05	0.00133	CbGpPWpGaD
